Table 1.
Number of isolates | Besifloxacin (μg/mL) MIC90 | Moxifloxacin (μg/mL) MIC90 | Gatifloxacin (μg/mL) MIC90 | |
---|---|---|---|---|
S. aureus | ||||
MSSA-CSa | 144 | 0.06 | 0.12 | 0.25 |
MRSA-CRb | 81 | 4 | 32 | 64 |
S. epidermidis | ||||
MSSE-CSc | 50 | 0.06 | 0.12 | 0.25 |
MRSE-CRd | 29 | 4 | 64 | 128 |
MIC90 values were obtained from susceptibility testing of 144 methicillin-sensitive, ciprofloxacin-sensitive S. aureus isolates.7
MIC90 values were obtained from susceptibility testing of 81 methicillin-resistant, ciprofloxacin-resistant S. aureus isolates.24
MIC90 values were obtained from susceptibility testing of 50 methicillin-sensitive, ciprofloxacin-sensitive S. epidermidis isolates.7
MIC90 values were obtained from susceptibility testing of 29 methicillin-resistant, ciprofloxacin-resistant S. epidermidis isolates.24
Abbreviations: MIC90, minimum inhibitory concentration to inhibit 90% of isolates; MSSA-CS, methicillin- and ciprofloxacin-sensitive S. aureus; MRSA-CR, methicillin- and ciprofloxacin-resistant S. aureus; MSSE-CS, methicillin- and ciprofloxacin-sensitive S. epidermidis; MRSE-CR, methicillin- and ciprofloxacin-resistant S. epidermidis.